Autologous umbilical cord blood mononuclear cell therapy for hypoplastic left heart syndrome: a nonrandomized control trial of the efficacy and safety of intramyocardial injections.

Saved in:
Bibliographic Details
Title: Autologous umbilical cord blood mononuclear cell therapy for hypoplastic left heart syndrome: a nonrandomized control trial of the efficacy and safety of intramyocardial injections.
Authors: Gallego-Navarro, Carlos1,2 (AUTHOR) gallegonavarro.carlos@mayo.edu, Jaggers, James3 (AUTHOR) James.Jaggers@childrenscolorado.org, Burkhart, Harold M.4 (AUTHOR) Harold-Burkhart@ouhsc.edu, Carlo, Waldemar F.5 (AUTHOR) wfcarlo@uabmc.edu, Morales, David L.6 (AUTHOR) david.morales@cchmc.org, Qureshi, M. Yasir2,7 (AUTHOR) qureshi.muhammad@mayo.edu, Rossano, Joseph W.8 (AUTHOR) rossanoj@chop.edu, Hagen, Clinton E.9 (AUTHOR) clint@webuildhearts.org, Seisler, Drew K.2 (AUTHOR) seisler.drew@mayo.edu, Peral, Susana Cantero1,2 (AUTHOR) canteroperal.susana@mayo.edu, Nelson, Timothy J.1,2,7,9,10 (AUTHOR) Nelson.Timothy@mayo.edu
Source: Stem Cell Research & Therapy. 5/1/2025, Vol. 16 Issue 1, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17576512
DOI:10.1186/s13287-025-04316-3